医学
重症监护医学
人口
风险评估
梅德林
内科学
肿瘤科
环境卫生
计算机安全
计算机科学
政治学
法学
作者
Hartmut Döhner,Courtney D. DiNardo,F R Appelbaum,Charles Craddock,Hervé Dombret,Benjamin L. Ebert,Pierre Fenaux,Lucy A. Godley,Robert P. Hasserjian,Richard A. Larson,Ross L. Levine,Yasushi Miyazaki,Dietger Niederwieser,Gert J. Ossenkoppele,Christoph Röllig,Jorge Sierra,Eytan M. Stein,Martin S. Tallman,Wen‐Chien Chou,Jianxiang Wang,Agnieszka Wierzbowska,Andrew H. Wei,Bob Löwenberg
出处
期刊:Blood
[American Society of Hematology]
日期:2024-08-12
标识
DOI:10.1182/blood.2024025409
摘要
The European LeukemiaNet (ELN) genetic risk classifications were developed based on data from younger adults receiving intensive chemotherapy. Emerging analyses from patients receiving less-intensive therapies prompted a proposal for an ELN genetic risk classification specifically for this patient population.
科研通智能强力驱动
Strongly Powered by AbleSci AI